The US biotech aims to bring its antibody-based therapies to human trials later in the year and to develop new candidate ...

The oversubscribed Series C financing round will support the clinical development of in vivo CAR-T cells for oncology and ...

The US gene therapy company Regenxbio and the Japanese firm Nippon Shinyaku have joined forces to boost the development and ...

The Swiss drug development company Windward Bio recently announced that it had officially launched with a $200 million Series ...

MaaT Pharma is focused on developing microbiome-related therapies and its lead candidate is MaaT013, a treatment for acute ...

The UK biopharma company Alchemab Therapeutics announced today that it has joined forces with Eli Lilly to discover, develop, ...